SpaceX's Filing Full Surprises Could Shift Markets Worldwide
Investors are eyeing a possible SpaceX IPO, with a prospectus that analysts say could redefine how a private tech emp...
Which Cash Back Cards Are Worth It
Identifying which cash back cards are worth it can enhance your financial strategy. Explore the top options for maximizing rewards.
25,607 articles
Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Alphabet Just Joined the Dow Amid Worst Month in Over a Year
Alphabet just joined the Dow as a tech giant moves into the benchmark amid a broad market downturn for its peers. The...
Watching SentinelOne Stock Heading Into March: Reasons
March brings renewed attention to sentinelone stock heading into a volatile market. This piece outlines why I’m watch...
Micron Could Be Cheap If AI Continues Scaling From Here
Micron Technology rides a surge in AI memory demand, delivering stronger margins and robust cash flow. As the company...
Inside the $1.7 Million Portfolio That Delivers $9,800 Monthly
A disciplined income strategy shows a $1.7 million portfolio that pays roughly $9,800 a month without selling shares,...
Stock Market Today, June: Coupang Rally Beats Worst-Case Fears
June 11 brought a surprising twist: Coupang’s privacy fine landed below feared levels, sending the stock higher and l...
Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Seven REIT Stocks Pass Screening; Yields Reach 6.27%
Seven REITs cleared a strict financial screen, delivering dividends as high as 6.27% and drawing investor attention a...
Turning Point Brands Stock Shines: A Thursday Rally
Turning Point Brands stock captured attention with a double-digit sales lift and solid earnings signs that stunned ma...
67-Year-Old Single Retiree with $920K: Can It Last to 95?
As inflation and market volatility shape retirement outcomes, a prudent plan can stretch a $920,000 nest egg. The key...
Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status